5-122077751-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_002317.7(LOX):​c.235G>A​(p.Ala79Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000425 in 1,562,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A79A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00045 ( 0 hom. )

Consequence

LOX
NM_002317.7 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 0.319

Publications

2 publications found
Variant links:
Genes affected
LOX (HGNC:6664): (lysyl oxidase) This gene encodes a member of the lysyl oxidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate a regulatory propeptide and the mature enzyme. The copper-dependent amine oxidase activity of this enzyme functions in the crosslinking of collagens and elastin, while the propeptide may play a role in tumor suppression. In addition, defects in this gene have been linked with predisposition to thoracic aortic aneurysms and dissections. [provided by RefSeq, Jul 2016]
SRFBP1 (HGNC:26333): (serum response factor binding protein 1) Enables RNA binding activity. Predicted to be involved in maturation of SSU-rRNA. Predicted to be located in perinuclear region of cytoplasm. Predicted to be part of 90S preribosome. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.036512703).
BP6
Variant 5-122077751-C-T is Benign according to our data. Variant chr5-122077751-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 521345.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000151 (23/152130) while in subpopulation NFE AF = 0.000294 (20/68012). AF 95% confidence interval is 0.000194. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 23 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOXNM_002317.7 linkc.235G>A p.Ala79Thr missense_variant Exon 1 of 7 ENST00000231004.5 NP_002308.2
SRFBP1XM_017009111.3 linkc.*2426C>T 3_prime_UTR_variant Exon 8 of 8 XP_016864600.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LOXENST00000231004.5 linkc.235G>A p.Ala79Thr missense_variant Exon 1 of 7 1 NM_002317.7 ENSP00000231004.4
LOXENST00000639739.2 linkn.235G>A non_coding_transcript_exon_variant Exon 1 of 6 5 ENSP00000492324.2

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000164
AC:
26
AN:
158608
AF XY:
0.000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000401
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000455
AC:
641
AN:
1410310
Hom.:
0
Cov.:
33
AF XY:
0.000402
AC XY:
281
AN XY:
698184
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32196
American (AMR)
AF:
0.00
AC:
0
AN:
37862
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25272
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37310
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81556
European-Finnish (FIN)
AF:
0.0000244
AC:
1
AN:
41000
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5650
European-Non Finnish (NFE)
AF:
0.000573
AC:
625
AN:
1090834
Other (OTH)
AF:
0.000256
AC:
15
AN:
58630
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
39
78
117
156
195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152130
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41444
American (AMR)
AF:
0.0000654
AC:
1
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000117
Hom.:
0
Bravo
AF:
0.000155
ExAC
AF:
0.000215
AC:
24

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
May 28, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified in two families with thoracic aortic aneurysms (TAA), one of whom harbored an additional disease-causing variant in the ACTA2 gene; authors report p.(A79T) as likely benign (PMID: 26838787); In silico analysis suggests that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 26838787) -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Apr 01, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: LOX c.235G>A (p.Ala79Thr) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00016 in 158608 control chromosomes. The observed variant frequency is approximately 99-fold of the estimated maximal expected allele frequency for a pathogenic variant in LOX causing Aortopathy phenotype (1.7e-06), suggesting that the variant could be benign. c.235G>A has been reported in the literature in at least one individual affected with familial thoracic aortic aneurysms and dissections with a reported alternate disease-causing ACTA2 mutation (e.g. Guo_2017). This report does not provide unequivocal conclusions about association of the variant with Aortopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 521345). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Acute aortic dissection;C0345050:Congenital aneurysm of ascending aorta Benign:1
Jan 12, 2016
University of Washington Center for Mendelian Genomics, University of Washington
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

- -

Cardiovascular phenotype Benign:1
Dec 13, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
3.0
DANN
Benign
0.87
DEOGEN2
Benign
0.22
T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.033
N
LIST_S2
Benign
0.46
.;T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.037
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.0
N;N
PhyloP100
0.32
PrimateAI
Pathogenic
0.79
T
PROVEAN
Benign
-0.93
N;.
REVEL
Benign
0.024
Sift
Benign
0.076
T;.
Sift4G
Benign
0.71
T;.
Polyphen
0.0
B;B
Vest4
0.10
MVP
0.15
MPC
0.52
ClinPred
0.027
T
GERP RS
-0.81
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.046
gMVP
0.36
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs752839330; hg19: chr5-121413446; API